𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant chemoimmunotherapy stage i/ii malignant melanoma

✍ Scribed by J. A. Knost; V. Reynolds; F. A. Greco; R. K. Oldham

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
490 KB
Volume
19
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant immunotherapy with BCG in stage
Adjuvant immunotherapy with BCG in stage II malignant melanoma
✍ M. J. Byrne; G. van Hazel; P. M. Reynolds; W. M. Lemish; C. D. J. Holman πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 223 KB

## Abstract Forty‐one patients were treated with BCG immunotherapy following block dissection of lymph nodes involved with malignant melanoma. A control group of similar patients who received no immunotherapy was drawn from a population consisting of all patients with malignant melanoma diagnosed i

Late recurrence of stage I malignant mel
Late recurrence of stage I malignant melanoma
✍ Mordechai Gutman; Joseph M. Klausner; Moshe Inbar; Ron R. Rozin πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 250 KB

Although the introduction of well-established risk factors has made the clinical course and prognosis of malignant melanoma disease much more predictable, in a considerable number of patients the disease's course is still not as expected. One group to which this applies are stage I melanoma patients

The value of preoperative screening proc
The value of preoperative screening procedures in stage I and II malignant melanoma
✍ Gerard V. Aranha; Richard L. Simmons; Audolfur Gunnarsson; Theodor B. Grace; Cha πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 338 KB πŸ‘ 1 views

## Abstract Fifty patients with melanoma (30 with clinical Stage I disease and 20 with clinical Stage II disease) were analyzed retrospectively along with the screening test done prior to surgery. While the value of the chest X ray is unquestioned in preoperative screening, the same cannot be said

Changes in survival with clinical stage
Changes in survival with clinical stage I malignant melanoma
✍ C. P. Karakousis; Dr. S. Kachrimanidis; U. Rao; L. J. Emrich πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 363 KB

Inclusion of patients referred to our cancer center following recurrence, by retracing the history and characteristics of these patients back to when they were in stage I, produced a bias that lowered the estimated diseasefree survival rates. However, taking into consideration only patients referred